Breast cancer, aromatase inhibitors, and bone health
Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
Pharmacology
FDA Approves Brexafemme For Recurrent Yeast Infections
The Food and Drug Administration (FDA) has approved Brexafemme (ibrexafungerp) for a second indication for reduction in incidence of recurrent…
Your Older Patients Would Like to Talk About Their Medications
Most patients over 50 are receptive to talking with their healthcare provider about taking fewer medications, but some are doing…